Quote:
Originally Posted by finnbow
This applies only to "orphan" drugs. I understand why Big Pharma is interested in having its US patents honored elsewhere for 20 years to correspond to our laws and I also understand why other countries are interested in manufacturing generics prior to expiration of these patents. As with many such issues, there are two sides to it and how you feel depends on where you sit.
|
"3. How long is exclusivity granted for?
It depends on what type of exclusivity is granted.
Orphan Drug (ODE) - 7 years
New Chemical (NCE)- 5 years
"Other" Exclusivity - 3 years for a "change" if criteria are met
Pediatric Exclusivity (PED) - 6 months added to existing Patents/Exclusivity
Patent Challenge – (PC) – 180 days (this exclusivity is for ANDAs only)
See 21 C.F.R. 314.1083 New Drug Product Exclusivity."